OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
OCX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
0.70%84.350.8%$420.58m
MDTMedtronic Plc
0.62%108.630.6%$357.25m
TMOThermo Fisher Scientific, Inc.
0.84%295.991.0%$357.14m
ISRGIntuitive Surgical, Inc.
0.84%549.362.4%$326.51m
BSXBoston Scientific Corp.
2.56%41.201.1%$314.06m
BDXBecton, Dickinson & Co.
-0.04%242.341.1%$310.36m
SYKStryker Corp.
0.92%200.241.3%$297.60m
BAXBaxter International, Inc.
1.60%80.121.8%$297.49m
DHRDanaher Corp.
0.79%135.580.7%$278.31m
ALGNAlign Technology, Inc.
0.14%258.976.4%$276.48m
EWEdwards Lifesciences Corp.
1.98%239.351.2%$272.31m
DXCMDexCom, Inc.
0.22%206.148.3%$240.09m
WMGIWright Medical Group NV
0.34%29.408.3%$236.99m
ABMDABIOMED, Inc.
1.57%223.543.3%$155.21m
PODDInsulet Corp.
1.90%177.306.7%$142.29m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.